Edaravone: Side Effects, Uses & Monitoring

Facts extracted from current FDA product labeling for Edaravone. Educational only — not medical advice.

Labeled uses

RADICAVA and RADICAVA ORS are indicated for the treatment of amyotrophic lateral sclerosis (ALS).

Source: FDA labeling via NIH DailyMed (set 0ce2c1c4…). Not affiliated with FDA or NIH.

Medical disclaimer: Always consult a qualified healthcare professional about any medication.